RenovaCare Inc. (OTCMKTS:RCAR – Get Free Report)’s stock price passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.00 and traded as high as $0.0001. RenovaCare shares last traded at $0.0001, with a volume of 2,046 shares traded.
RenovaCare Stock Down 50.0%
RenovaCare Company Profile
RenovaCare, Inc, a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area.
See Also
- Five stocks we like better than RenovaCare
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Wall Street Loves Williams-Sonoma Right Now—Here’s Why the Stock Could Soar in 2026
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Meta Wins FTC Fight, Keeps Instagram Growth Machine Intact
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Red Cups or Red Flags: Starbucks’ Bet on a Holiday Recovery
Receive News & Ratings for RenovaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RenovaCare and related companies with MarketBeat.com's FREE daily email newsletter.
